The ScentAware Digital Olfactory Test represents a transformative advancement in the early detection and management of neurodegenerative diseases. Leveraging the established link between olfactory dysfunction and conditions such as Alzheimer’s and Parkinson’s disease—where smell loss can precede motor symptoms by up to a decade—ScentAware offers a rapid, self-administered, and culturally adapted screening tool suitable for both clinical and home settings. By capturing real-time data on odor identification and hedonic pleasantness, the test utilises a multi-modal approach to facilitate early risk stratification and supports clinical decision-making when combined with other biomarkers, whilst simultaneously integrating with electronic medical records for scalable deployment. Backed by robust normative data and validated against established benchmarks, ScentAware provides a cost-effective, accessible solution to enhance trial triage, improve diagnostic accuracy, and ultimately accelerate intervention in the fight against neurodegeneration.